Literature DB >> 2679113

Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model.

B A Valentine1, J F Cummings, B J Cooper.   

Abstract

The development of cardiac lesions was studied in xmd dogs aged from 1 day to 6 years. Cardiac lesions were not present in dystrophic dogs up to 3 months of age. Foci of mineralization were first seen at 6.5 months. A 1-year-old dog had foci of myocyte hypercontraction. Linear and anastomosing fibrosis was present in all dogs 1 year of age or older, most prominently and most consistently within the subepicardial region of the left ventricular (LV) free wall, the LV papillary muscles, and the right ventricular (RV) aspect of the septum. Ultrastructurally, endomysial fibrosis, decreased myofibrillar density, and prominence of mitochondria were consistent features. Severe degenerative changes were present in two dogs and included prominent intracytoplasmic myelin figures, lipid droplets, and lipofuscin. Immunocytochemical studies of an affected dog confirmed the absence of dystrophin in LV myocardium. Characteristic late-onset cardiac lesions, similar to those occurring in Duchenne dystrophy, are a consistent feature of canine X-linked muscular dystrophy (CXMD).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679113      PMCID: PMC1880020     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Myopathies in the dog.

Authors:  H MEIER
Journal:  Cornell Vet       Date:  1958-07

2.  Cell and fiber-type distribution of dystrophin.

Authors:  E P Hoffman; M S Hudecki; P A Rosenberg; C M Pollina; L M Kunkel
Journal:  Neuron       Date:  1988-07       Impact factor: 17.173

3.  Natural course of cardiomyopathy in Duchenne muscular dystrophy.

Authors:  H Tanaka; S Nishi; H Katanasako
Journal:  Jpn Circ J       Date:  1979-11

4.  Cardiac function in Duchenne's muscular dystrophy. Results of 10-year follow-up study and noninvasive tests.

Authors:  R H Hunsaker; P K Fulkerson; F J Barry; R P Lewis; C V Leier; D V Unverferth
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

Review 5.  Morphological changes in dystrophic muscle.

Authors:  M J Cullen; F L Mastaglia
Journal:  Br Med Bull       Date:  1980-05       Impact factor: 4.291

6.  Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles.

Authors:  J W Carnwath; D M Shotton
Journal:  J Neurol Sci       Date:  1987-08       Impact factor: 3.181

7.  The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates.

Authors:  L F Torres; L W Duchen
Journal:  Brain       Date:  1987-04       Impact factor: 13.501

8.  Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide.

Authors:  K Arahata; S Ishiura; T Ishiguro; T Tsukahara; Y Suhara; C Eguchi; T Ishihara; I Nonaka; E Ozawa; H Sugita
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

9.  Life spans of Duchenne muscular dystrophy patients in the hospital care program in Japan.

Authors:  M Mukoyama; K Kondo; K Hizawa; H Nishitani
Journal:  J Neurol Sci       Date:  1987-11       Impact factor: 3.181

10.  An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy.

Authors:  S K Sanyal; W W Johnson; M K Thapar; S E Pitner
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

View more
  21 in total

1.  Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs.

Authors:  Deborah M Fine; Jin-Hong Shin; Yongping Yue; Dietrich Volkmann; Stacey B Leach; Bruce F Smith; Mark McIntosh; Dongsheng Duan
Journal:  Neuromuscul Disord       Date:  2011-05-13       Impact factor: 4.296

Review 2.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

Review 3.  Dystrophin-deficient large animal models: translational research and exon skipping.

Authors:  Xinran Yu; Bo Bao; Yusuke Echigoya; Toshifumi Yokota
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

4.  Chronic administration of membrane sealant prevents severe cardiac injury and ventricular dilatation in dystrophic dogs.

Authors:  Dewayne Townsend; Immanuel Turner; Soichiro Yasuda; Joshua Martindale; Jennifer Davis; Michael Shillingford; Joe N Kornegay; Joseph M Metzger
Journal:  J Clin Invest       Date:  2010-03-15       Impact factor: 14.808

Review 5.  Metabolic regulation of in vivo myocardial contractile function: multiparameter analysis.

Authors:  M D Osbakken
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

6.  Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.

Authors:  Paul T Martin; G Diane Shelton; Peter J Dickinson; Beverly K Sturges; Rui Xu; Richard A LeCouteur; Ling T Guo; Robert A Grahn; Harriet P Lo; Kathryn N North; Richard Malik; Eva Engvall; Leslie A Lyons
Journal:  Neuromuscul Disord       Date:  2008-11-05       Impact factor: 4.296

7.  Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.

Authors:  Justin C DeVanna; Joe N Kornegay; Daniel J Bogan; Janet R Bogan; Jennifer L Dow; Eleanor C Hawkins
Journal:  Neuromuscul Disord       Date:  2013-10-24       Impact factor: 4.296

Review 8.  Small and large animal models in cardiac contraction research: advantages and disadvantages.

Authors:  Nima Milani-Nejad; Paul M L Janssen
Journal:  Pharmacol Ther       Date:  2013-10-15       Impact factor: 12.310

9.  Experimental models of duchenne muscular dystrophy: relationship with cardiovascular disease.

Authors:  Venus Ameen; Lesley G Robson
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

10.  A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping.

Authors:  Gemma L Walmsley; Virginia Arechavala-Gomeza; Marta Fernandez-Fuente; Margaret M Burke; Nicole Nagel; Angela Holder; Rachael Stanley; Kate Chandler; Stanley L Marks; Francesco Muntoni; G Diane Shelton; Richard J Piercy
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.